Eloxx Pharmaceuticals, Inc. (ELOX) vs Lite Strategy, Inc. (LITS)

A side-by-side comparison of Eloxx Pharmaceuticals, Inc. and Lite Strategy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ELOX

Eloxx Pharmaceuticals, Inc.

$50M

$14.63HealthcareDelayed quote: Oct 6, 2026, 2:30 PM EDT

LITS

Lite Strategy, Inc.

$48M

$1.41HealthcareDelayed quote: Oct 6, 2026, 2:23 PM EDT

Total return — ELOX vs LITS

growth of $100 · dividends reinvested · last 1y

ELOX +40.0% (+40.0%/yr)LITS +85.1% (+85.1%/yr)LITS compounded faster over this window

ELOX LITS

Metrics side by side

Total return (annualized)

Metric	ELOX	LITS
Total return (1Y)	N/A	-45.15%

ELOX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ELOX analysis Full LITS analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.